ResearcherAkita UniversityNo recent work listed
Yuzo Yamamoto
Matched on ORCID iD 0000-0001-5178-9169; OpenAlex author ID A5002135562. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 19
2014: 2 papers · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: 1 paper
Papers 3
- Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis. Co-author DOI 10.1002/jhbp.1127↗
- The roles of interferon regulatory factors 1 and 2 in the progression of human pancreatic cancer. Co-author DOI 10.1097/mpa.0000000000000116↗
- High-dose corticosteroid therapy for erlotinib-induced interstitial lung disease in Japanese patient with advanced pancreatic cancer. Last author DOI 10.6092/1590-8577/2857↗
Closest collaborators
The 19 strongest of 19 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Masakazu Yamamoto · 1 shared paper, 2022 · strength 0.11
- Yuki Homma · 1 shared paper, 2022 · strength 0.11
- Yoshifumi Morita · 1 shared paper, 2022 · strength 0.11
- Yasuji Seyama · 1 shared paper, 2022 · strength 0.11
- Kazuhiro Yoshida · 1 shared paper, 2022 · strength 0.11
- Shugo Mizuno · 1 shared paper, 2022 · strength 0.11
- Masayuki Sho · 1 shared paper, 2022 · strength 0.11
- Hiroki Yamaue · 1 shared paper, 2022 · strength 0.11
- Yutaka Takeda · 1 shared paper, 2022 · strength 0.11
- Yuko Mataki · 1 shared paper, 2022 · strength 0.11
- Masaji Tani · 1 shared paper, 2022 · strength 0.11
- Satoshi Hirano · 1 shared paper, 2022 · strength 0.11
- Toshiki Rikiyama · 1 shared paper, 2022 · strength 0.11
- Hideo Baba · 1 shared paper, 2022 · strength 0.11
- Itaru Endo · 1 shared paper, 2022 · strength 0.11
- Masato Yoshioka · 2 shared papers, 2014 · strength 0.08
- Hirohide Ohnishi · 1 shared paper, 2014 · strength 0.04
- Hirosato Mashima · 1 shared paper, 2014 · strength 0.04
- Toshitaka Sakai · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.